Rare diseases
Investigational molecules
Locations
Avenida Brasilia S/n, 1400-038 Lisbon, Portugal
Clinical research at the Champalimaud Clinical Centre includes studies in triple-negative breast cancer, with attention to tumour-infiltrating lymphocytes, immune activation, and checkpoint inhibitor-based treatment strategies.
The centre’s breast cancer studies focus on locally advanced and high-risk disease, with interest in identifying immune-related features linked to treatment response.
Champalimaud Clinical Centre runs clinical trials in conditions such as Breast cancer, Breast cancer metastatic, Breast cancer female, Ovarian cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PortugalPortugalIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
